| Evaluation of Alternative Diagnostic Follow-up Intervals for Lung Reporting and Data System Criteria on the Effectiveness of Lung Cancer Screening. |
34419477
|
Bastani M, Toumazis I, Hedou' J, Leung A, Plevritis SK |
J Am Coll Radiol |
2021 |
NLST |
| Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts. |
33820799
|
Fuhrman BJ, Moore SC, Byrne C, Makhoul I, Kitahara CM, Berrington de González A, Linet MS, Weiderpass E, Adami HO, Freedman ND, Liao LM, Matthews CE, Stolzenberg-Solomon RZ, Gaudet MM, Patel AV, Lee IM, Buring JE, Wolk A, Larsson SC, Prizment AE, Ro… |
Cancer Res |
2021 |
PLCO |
| Genetic variants of DOCK2, EPHB1 and VAV2 in the natural killer cell-related pathway are associated with non-small cell lung cancer survival. |
34094683
|
Du H, Liu L, Liu H, Luo S, Patz EF, Glass C, Su L, Du M, Christiani DC, Wei Q |
Am J Cancer Res |
2021 |
PLCO |
| Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality. |
34205398
|
Bibault JE, Hancock S, Buyyounouski MK, Bagshaw H, Leppert JT, Liao JC, Xing L |
Cancers (Basel) |
2021 |
PLCO |
| An investigation of cross-sectional associations of a priori-selected dietary components with circulating bile acids. |
34477829
|
Byrd DA, Sinha R, Weinstein SJ, Albanes D, Freedman ND, Sampson J, Loftfield E |
Am J Clin Nutr |
2021 |
PLCO |
| Association of genetic variants in autophagy-lysosome pathway genes with susceptibility and survival to prostate cancer. |
34500048
|
Zhu Q, Meng Y, Li S, Xin J, Du M, Wang M, Cheng G |
Gene |
2021 |
PLCO |
| Assisted versus Manual Interpretation of Low-Dose CT Scans for Lung Cancer Screening: Impact on Lung-RADS Agreement. |
34559005
|
Jacobs C, Schreuder A, van Riel SJ, Scholten ET, Wittenberg R, Wille MMW, de Hoop B, Sprengers R, Mets OM, Geurts B, Prokop M, Schaefer-Prokop C, van Ginneken B |
Radiol Imaging Cancer |
2021 |
NLST |
| Generalizability and Transportability of the National Lung Screening Trial Data: Extending Trial Results to Different Populations. |
34548326
|
Inoue K, Hsu W, Arah OA, Prosper AE, Aberle DR, Bui AAT |
Cancer Epidemiol Biomarkers Prev |
2021 |
NLST |
| Scan-based competing death risk model for re-evaluating lung cancer computed tomography screening eligibility. |
34649976
|
Schreuder A, Jacobs C, Lessmann N, Broeders MJM, Silva M, Išgum I, de Jong PA, van den Heuvel MM, Sverzellati N, Prokop M, Pastorino U, Schaefer-Prokop CM, van Ginneken B |
Eur Respir J |
2021 |
NLST |
| Doubly robust nonparametric instrumental variable estimators for survival outcomes. |
34676400
|
Lee Y, Kennedy EH, Mitra N |
Biostatistics |
2021 |
PLCO |
| Gut Microbiome-Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort. |
34711629
|
Reichard CA, Naelitz BD, Wang Z, Jia X, Li J, Stampfer MJ, Klein EA, Hazen SL, Sharifi N |
Cancer Epidemiol Biomarkers Prev |
2021 |
PLCO |
| Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival. |
34692492
|
Liu L, Liu H, Luo S, Patz EF, Glass C, Su L, Lin L, Christiani DC, Wei Q |
Front Oncol |
2021 |
PLCO |
| Incidence of Second Primary Lung Cancer After Low-Dose Computed Tomography vs Chest Radiography Screening in Survivors of Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial. |
34709369
|
Cramer JD, Grauer J, Sukari A, Nagasaka M |
JAMA Otolaryngol Head Neck Surg |
2021 |
NLST |
| Association of a Deep Learning Estimation of Chest Imaging Age With Survival in Patients With Non-Small Cell Lung Cancers Undergoing Radiation. |
34700420
|
Perni S, Raghu V, Guthier CV, Weiss J, Huynh E, Hosny A, Fite E, Christiani D, Aerts H, Lu M, Mak RH |
Int J Radiat Oncol Biol Phys |
2021 |
NLST |
| Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer Risks. |
34648946
|
Robbins HA, Cheung LC, Chaturvedi AK, Baldwin DR, Berg CD, Katki HA |
J Thorac Oncol |
2021 |
NLST |
| Incidental Findings on Low-Dose CT Scan Lung Cancer Screenings and Deaths From Respiratory Diseases. |
34838524
|
Pinsky PF, Lynch DA, Gierada DS |
Chest |
2021 |
NLST |
| Mediastinal Lymphadenopathy in the National Lung Screening Trial (NLST) Is Associated with Interval Lung Cancer. |
34812667
|
Chalian H, McAdams HP, Lee Y, Duan F, Wu Y, Khoshpouri P, Patz EF |
Radiology |
2021 |
NLST |
| Lung Cancer Risk among Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap. |
34019783
|
Charokopos A, Braman SS, Brown SAW, Mhango G, de-Torres JP, Zulueta JJ, Sharma S, Holguin F, Sigel KM, Powell CA, Federman AD, Wisnivesky JP |
Ann Am Thorac Soc |
2021 |
NLST |
| Inference of Sojourn Time and Transition Density using the NLST X-ray Screening Data in Lung Cancer. |
34765725
|
Rahman F, Wu D |
Med Res Arch |
2021 |
NLST |
| Ovarian Cancer Prediction from Ovarian Cysts Based on TVUS Using Machine Learning Algorithms |
|
Akter L., Akhter N. |
Proceedings of the International Conference on Big Data, IoT, and Machine Learning |
2021 |
PLCO |
